Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

severe asthma

  • Behavior change to increase physical activity reduces sleep disturbances in asthma: A randomized controlled trial
    P Freitas, N F Passos, A Cukier, R Carvalho-Pinto, C R Fernandes de Carvalho
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4207; DOI: 10.1183/13993003.congress-2022.4207
  • A case of excavated pneumopathy after bronchial thermoplasty
    M Steger, N Khayath, M Ohana, N Migueres, C Marcot, F De Blay, N Migueres
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4216; DOI: 10.1183/13993003.congress-2022.4216
  • Metformin: A potential drug candidate to restore poor corticosteroid sensitivity in obese asthmatic patients
    M To, N Honda, K Haruki, Y To
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4344; DOI: 10.1183/13993003.congress-2022.4344
  • Achievement rate and predictive factors of the deep remission to biologics in severe asthma
    K Oishi, K Hamada, Y Murata, Y Yamaji, M Asami, N Edakuni, T Hirano, K Matsunaga
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4401; DOI: 10.1183/13993003.congress-2022.4401
  • Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the ALLIANCE cohort
    A J Hose, E Von Mutius, K F Rabe, G Hansen, M V Kopp, M J Ege
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4604; DOI: 10.1183/13993003.congress-2022.4604
  • Waning of biologic effect at end of dosing interval perceived by patients with severe asthma
    J A Kroes, L H G Van Hal, L Van Dijk, S W Zielhuis, E N Van Roon, A Ten Brinke, J A Kroes
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4351; DOI: 10.1183/13993003.congress-2022.4351
  • The PARP14 inhibitor RBN-3143 suppresses lung inflammation in preclinical models
    M Niepel, M Vasbinder, J Molina, B Gui, K Kunii, D Blackwell, E Mateer, J Mo, C Coutts, N Perl, K Kuplast-Barr, W Church, C Majer, L B Schenkel, K Swinger, R Abo, E Bamberg, Y Ren, L Utley, T Wigle, C Reik, A Lu, A Cheung, E Minissale, K Mceachern, V Richon, S Parasuraman, K Kuntz, H Keilhack
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4642; DOI: 10.1183/13993003.congress-2022.4642
  • Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data
    J A Kroes, R Alfonso-Cristancho, A T Bansal, E Berret, K Bieksiene, A Bourdin, L Brussino, D Canhoto, C Cardini, G Celik, Z Csoma, B Dahlén, E Damadoğlu, K Eger, L Gauquelin, B Gemicioglu, O Goksel, S Graff, E Heffler, H B Hofstee, P Howarth, R Jakes, F Jaun, V Kalinauskaite-Zukauske, P Kopač, N Kwon, C C Loureiro, V Lozoya García, M Masoli, M Paula Rezelj, L Pérez De Llano, S Popović-Grle, D Ramos-Barbon, A Sà Sousa, K Samitas, F Schleich, C Sirena, S Skrgat, E Zervas, G Zichnalis, E H Bel, J K Sont, S Hashimoto, A Ten Brinke
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4340; DOI: 10.1183/13993003.congress-2022.4340
  • Predictors of poor disease control and impaired quality of life (QOL) in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC)
    V Bataduwaarachchi, T Brown, L Wiffen, T Jones, C Barber, P Howarth, C Anoop
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4228; DOI: 10.1183/13993003.congress-2022.4228
  • International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs
    C Caruso, G W Canonica, M Patel, A Smith, M C Liu, R Alfonso-Cristancho, R G Price, R W Jakes, L Demetriou, A Valero, C Pilette, P Howarth
    European Respiratory Journal Sep 2022, 60 (suppl 66) 4589; DOI: 10.1183/13993003.congress-2022.4589

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 40
  • Acute lung injury and critical care (83)
  • Asthma and allergy (674)
  • CF and non-CF bronchiectasis (288)
  • COPD and smoking (920)
  • Epidemiology, occupational and environmental lung disease (220)
  • Genetics (61)
  • Interstitial and orphan lung disease (517)
  • Lung biology and experimental studies (321)
  • Lung cancer (285)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (396)
  • Pulmonary pharmacology and therapeutics (142)
  • Pulmonary vascular disease (532)
  • Respiratory clinical practice (174)
  • Respiratory infections and tuberculosis (986)
  • Sleep medicine (272)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • Lung volumes and forced ventilatory flows
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society